MCAM

MCAM

MCAM 詳細

Molecule Name
Melanoma cell adhesion molecule
分子の別称
MCAM,CD146,MUC18
Drug Development Progress
治験薬の数2
市販薬剤の数0
研究&開発段階Phase 2 Clinical
ターゲットの別称
METCAM,CD146,Melanoma cell adhesion molecule,MCAM,Cell surface glycoprotein MUC18,S-Endo 1 Endothelial-Associated Antigen,Melanoma-Associated Antigen MUC18,Melanoma-Associated Antigen A32,Gicerin,MUC18,CD146 Antigen,Cell surface glycoprotein P1H12,Melanoma Adhesion Molecule,MelCAM,HEMCAM
バックグランド
CD146, also known as the melanoma cell adhesion molecule (MCAM) or cell surface glycoprotein MUC18, is a 113kDa cell adhesion molecule currently used as a marker for endothelial cell lineage. As a member of the Immunoglobulin superfamily, It is expressed on chicken embryonic spleen and thymus, activated human T cells, endothelial progenitors such as angioblasts and mesenchymal stem cells, and strongly expressed on blood vessel endothelium and smooth muscle. CD146 has been demonstrated to appear on a small subset of T and B lymphocytes in the peripheral blood of healthy individuals. The CD146+ T cells display an immunophenotype consistent with effector memory cells and have a distinct gene profile from the CD146- T cells. As a Ca2+ independent cell adhesion molecule involved in heterophilic cell to cell interactions and a surface receptor,CD146 triggers tyrosine phosphorylation of FYN and PTK2 and subsequently induced signal transduction, proteolysis or immune recognition.

MCAM 製品リスト

No Data
You Have Viewed 0 Of 0 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
CD146 targeting CAR-T cell therapy (Essen Biotech)Phase 2 ClinicalEssen Biotech
Carcinoma, Ovarian Epithelial; Osteosarcoma; Ovarian Neoplasms; Sarcoma; Sarcoma, Ewing; Sarcoma, Kaposi; Sarcoma, Synovial
詳細
AMT-253(Multitude)AMT-253; AMT-253 ADCPhase 2 ClinicalMultitude Therapeutics Inc
Melanoma; Solid tumours
詳細